Analytical & Bioanalytical Services
Contract Research Organization
Clinical Trial Supply & Logistics
Regulatory, Tech Transfer & Support Services
Company Overview
About
ICON plc is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Australia
Founded:2016
Employees:133
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Europe
Regulatory Approvals
Drug Approval 0A4NC1
PMDA · #APR-JSTIZHEM · 2020-08-01
Drug Approval JDBS0L
PMDA · #APR-78UXQVPM · 2021-06-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-TO7UYIQW
Issued: 2020-11-16
Expires: 2025-02-15
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-KJO6B3J2
Issued: 2020-03-24
Expires: 2025-12-12
Health Canada GMP
Health Canada
Cert #: CERT-ENCAB1OK
Issued: 2020-07-22
Expires: 2025-04-02
Loading CDMO intelligence...
Key facts about ICON plc
- ICON plc is headquartered in Australia.
- ICON plc was founded in 2016.
- ICON plc has 133 employees.
- ICON plc's capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like ICON plc
Directory pages this company appears in, each with the full list of matching manufacturers.